Galux and Boehringer Ingelheim Announce Strategic Research Agreement Galux, a South Korean biotech innovator specializing in AI-driven protein therapeutics discovery, has entered a strategic research agreement with Boehringer Ingelheim. The collaboration aims to jointly explore and advance AI-assisted protein design, with a focus on accelerating the identification and optimization of novel therapeutic candidates. The partnership…